Company News: Curetis to Present at Solebury Trout European Biotech Investor Day in NYC

Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that its CEO Oliver Schacht, PhD, will present at the European Biotech Investor Day in New York City, NY, USA, on Thursday, August 1, 2019, at 4pm EST. The life science-focused conference is organized by Solebury Trout and sponsored by Goodwin LLC, Deutsche Bank, H.C. Wainwright and Nasdaq and will be held at offices of Goodwin LLC in the New York Times building.

Oliver Schacht will discuss the progressing commercialization of the Unyvero multiplex PCR platform for molecular microbiology in the U.S., Europe, and Asia and provide an update on partnering activities around the Company´s A30 RQ Platform in development and the recent progress in offering AI-powered, NGS-based molecular microbiology solutions by Curetis’ subsidiary Ares Genetics.